Arcadia Biosciences Announces First-Quarter 2020 Financial Results and Business Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Arcadia Biosciences (RKDA) Tops Q1 EPS by 83c, Revenues Miss; Reiterates FY20 Revenue Guidance Above Consensus
May 13, 2020 4:16 PM EDTArcadia Biosciences (NASDAQ: RKDA) reported Q1 EPS of $0.29, $0.83 better than the analyst estimate of ($0.54). Revenue for the quarter came in at $309 thousand versus the consensus estimate of $800 thousand.
"This is an extraordinary moment in time for all of us," said Matt Plavan, Arcadia's president and chief executive officer. "Our priorities throughout this challenging time remain the same: to maintain the health and safety of... More
